Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA dermatology"
DOI: 10.1001/jamadermatol.2021.5992
Abstract: Importance Junctional epidermolysis bullosa (JEB) is an incurable blistering skin disorder with high infant mortality often caused by nonsense variants in the genes that encode laminin 332. Objective To evaluate the safety and outcomes following… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA Oncology"
DOI: 10.1001/jamaoncol.2022.5959
Abstract: This nonrandomized controlled trial evaluates the clinical benefits and safety of atezolizumab plus bevacizumab for treatment of patients with metastatic non–small cell lung cancer (NSCLC) with high tumor mutation burden. read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.51715
Abstract: HTLV‐1 infection causes HTLV‐1‐associated myelopathy/tropical spastic paraparesis (HAM/TSP), resulting in loss of motor function. In this Phase 2 trial, we assessed the efficacy and safety of l‐arginine in patients with HAM/TSP. read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Cancer"
DOI: 10.1002/cncr.35185
Abstract: Lenvatinib is approved as a first‐line treatment for patients with unresectable and/or recurrent hepatocellular carcinoma (HCC). Lenvatinib achieved promising clinical benefits in REFLECT but was associated with clinically significant treatment‐emergent hypertension (CSTE‐HTN, a grouped term),… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "European Journal of Pain"
DOI: 10.1002/ejp.2039
Abstract: The aim of this study was to assess the effectiveness and cost‐effectiveness of Pilates versus aerobic exercises in the treatment of patients with fibromyalgia syndrome from a societal perspective. read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Hematological Oncology"
DOI: 10.1002/hon.69_2631
Abstract: 357 COPANLISIB TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MARGINAL ZONE LYMPHOMA P. Panayiotidis | A. Kellner | G.A. Follows | L. Mollica | A. Nagler | M. Özcan | A. Santoro | F. Hiemeyer… read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "Journal of Ultrasound in Medicine"
DOI: 10.1002/jum.15389
Abstract: One of the most concerning characteristics of the severe acute respiratory syndrome coronavirus 2 pandemic is its fast contagion rate: the number of total confirmed cases grows approximately exponentially in many countries. In this rapidly… read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "Advances in experimental medicine and biology"
DOI: 10.1007/978-3-030-63761-3_42
Abstract: A newly discovered coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the ongoing pandemic of coronavirus disease 2019 (COVID-19), which is not only physically challenging but also has many subtle and overt… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Pain"
DOI: 10.1007/978-3-319-99124-5_243
Abstract: Effective pharmacotherapy is a valuable tool to treat addiction disorders. It has included partial μ agonist, such as buprenorphine, and μ opioid agonists, such as methadone. The pharmacological basis of maintenance treatment of dependent individuals… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "Cardiovascular and Interventional Radiology"
DOI: 10.1007/s00270-025-04051-5
Abstract: To investigate the influence of sarcopenia on the outcomes of endovascular treatment in patients with pelvic venous insufficiency (PVI). A retrospective analysis was conducted on 62 female patients who underwent endovascular treatment for PVI between… read more here.